Publicaciones en las que colabora con Teresa Díaz Perdigón (9)

2023

  1. Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121

  2. SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 529-550

2021

  1. Primary role for melatonin MT2 receptors in the regulation of anhedonia and circadian temperature rhythm

    European Neuropsychopharmacology, Vol. 44, pp. 51-65

2020

  1. Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model

    Neuropsychopharmacology, Vol. 45, Núm. 2, pp. 347-357

  2. THE SAMP8 MOUSE AS A MODEL OF ACCELERATED SENESCENCE

    Encyclopedia of Cell Biology: New Research (9 Volume Set) (Nova Science Publishers, Inc.), pp. 1465-1492

2019

  1. The compound 33i,a new sirt2 inhibitor, as a potential treatment for Alzheimer's disease

    The compound 33i,a new sirt2 inhibitor, as a potential treatment for Alzheimer's disease

2018

  1. The SAMP8 mouse as a model of accelerated senescence

    New Research on Cell Aging and Death (Nova Science Publishers, Inc.), pp. 1-42

2017

  1. SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action

    Neuropharmacology, Vol. 117, pp. 195-208

  2. SIRT2 inhibition reverses anhedonia in the VGLUT1+/− depression model

    Behavioural Brain Research, Vol. 335, pp. 128-131